Michalski Htteramnn & Partner competitive analysis

Explore patent oppositions filed by Michalski Htteramnn & Partner against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Jul 2, 2026
Patent NumberTitleApplicantOpposition Date
Methods For Treating Or Preventing Asthma By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALSOct 10, 2024
Adjuvant Treatment Of Her2-Positive Breast CancerF HOFFMANN LA ROCHEAug 1, 2024
Methods For Treating Or Preventing Asthma By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALSAug 1, 2024

Latest PTAB cases involving Michalski Htteramnn & Partner

Discover the latest PTAB cases involving Michalski Htteramnn & Partner, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Michalski Htteramnn & Partner with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jul 2, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
MICHALSKI HTTERAMNN & PARTNER3 - - -
F HOFFMANN LA ROCHE16187 - -
REGENERON PHARMACEUTICALS38110932
SANOFI BIOTECHNOLOGY - 60 - -